Björn Steffen

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Hubert Serve, Utz Krug, Ruth Wagner et al. · Journal of Clinical Oncology · 2013 · 310 citations · Full text

Medicine, Oncology, Pharmacology +15

Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells

Carsten Müller‐Tidow, Björn Steffen, Thomas Cauvet et al. · Molecular and Cellular Biology · 2004 · 306 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations

Masao Mizuki, Joachim Schwäble, Claudia Steur et al. · Blood · 2003 · 296 citations · Full text

Medicine, Hematology, Molecular Biology +12

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

Jörge E. Cortes, Alexander E. Perl, Hartmut Döhner et al. · The Lancet Oncology · 2018 · 264 citations · Full text

Medicine, Hematology, Oncology +11

S100 Family Members and Trypsinogens Are Predictors of Distant Metastasis and Survival in Early-Stage Non-Small Cell Lung Cancer

Sven Diederichs, Etmar Bulk, Björn Steffen et al. · Cancer Research · 2004 · 190 citations

Medicine, Molecular Biology, Oncology +17